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Abstract— In this work, we present a novel microfluidic 
impedance biosensor chip for trapping both a single and 
multiple cancer cells and monitoring their response to 
the anticancer drug treatment. By designing different 
sizes of working microelectrodes together with the V-
shaped cell capture structures, a single or multiple cells 
are trapped on the microelectrodes surfaces. In addition, 
by utilizing the passive pumping method, cells can be 
trapped and positioned inside the microchannels without 
the need of using the outer micro pump or syringe. The 
impedance change induced by the response of cells to the 
anticancer drug Cisplatin treatment was successfully 
recorded. The proposed biosensor chip has a great po-
tential for applications in cancer cell research, drug 
screening, and quantification of cancer cells from vari-
ous tumor stages. The results of this study open potential 
research collaborations about development of cost-
effective devices and lab-on-chips for early disease de-
tection, studies of cancerous cells and their response to 
anti-cancer drugs to optimize cancer treatments, charac-
terisation of mechanical properties of cells, new drug 
delivery mechanisms, and micro and nano manufactur-
ing.  
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I. INTRODUCTION  
Cell-based impedance biosensors have been recognized 
as valuable and powerful tools for detecting biochemical 
effects such as cellular physiological changes [1], pharma-
ceutical effects [2], and environmental toxicities [3].  It can 
be used to study various cellular activities in a real-time, 
label-free and nondestructive manner, including cell spread-
ing, growth, and motility; this is done via monitoring the 
electrical alternations at the interfaces between the cell and 
electrode [4,5]. For conventional cell-based sensors, a large 
cell population is normally used, and they are randomly 
seeded on the top of big-sized electrodes, due to their lim-
ited ability to trap and control a single cell [2, 6]. Therefore, 
the average measurement is assumed to represent the behav-
ior of a typical cell within a cell population. This might lead 
to the inaccuracy or misleading results [7]. Therefore, there 
has been an emerging demand to develop innovative and 
smart devices which are able to be used to study the behav-
iors and signals from a single cell. 
Recently, the fast advancements of microfluidic tech-
niques as well as micro and nano manufacturing brought 
many advantages for single cell studies [8, 9]. By owning 
unique features such as a small size, laminar flow, and small 
volumes of samples and reagents, chip-based microfluidics 
have attracted the growing attention about a single cell 
monitoring and analysis. The proposed microfluidic sensor 
chip in this work can capture a single and multiple breast 
cancer MCF-7 cells on the microelectrode surface for moni-
toring the sequential cellular behavior and testing the anti-
cancer drug.  
The rest of the paper is organized as follows. Section II 
presents design and fabrication of a chip and experiments. 
Section III discusses the main results and challenges of 
using microfluidics for single cell studies. Finally, Section 
IV presents conclusions and addresses the potential collabo-
rations in Biomedical Engineering (BME), especially 
among research institutions in Vietnam and UK.     
II. MATERIALS AND METHOD 
A. Microfluidic chip design and fabrication process 
 
The microfluidic impedance biosensor comprises three 
main parts, including the sensing, the cell capture structures, 
and the microfluidic.  Fig. 1 presents a packaged chip with 
the sensing and cell trap structures. By utilizing the electri-
cal cell-substrate impedance sensing technique [10], the 
sensing part composes of Microelectrode Arrays (MEAs) 
which are patterned in two identical channels (see Fig.1 
(b)). In each channel, the MEAs comprises four columns of 
a working microelectrode (WE) which are located symmet-
rically on two sides of a rectangular large counter electrode 
(CE, 350 500 µm2). Two columns of the WEs on one side 
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of the CE are shifted by 40 μm in order to increase the cell 
trapping effectiveness from the cell suspension flow. The 
WEs are in a square of 25x25 µm and 60x60µm to host 
single cells and multiple cells respectively. 
The cell capture structures are designed and arranged 
corresponding to the each working microelectrode. Each 
cell-trap composes of two identical blocks placing closely 
together to form a V-shaped recess. There are small gaps 
between these two blocks to allow the hydrodynamic flow 
passing through and avoiding the captured cells. The novel 
design of the V-shaped cell-trap in this work leads to the 
higher cell trapping efficiency. In addition, it can overcome 
the limitations of conventional hydrodynamic cell trapping 
methods [11]. 
 
 
 
 
 
 
 
 
 
Fig.1 (a): An image of a packaged chip. (b): A micrograph 
of a Microelectrode Array with the 3D cell capture struc-
tures  
There are two different size of trap corresponding to the 
size of the WEs which aim to capture single or multiple 
cells on the top of microelectrodes. The V-shaped traps on 
two sides of the CE are placed oppositely to each other and 
their recesses are arranged toward the inlets for trapping 
cells from the cell suspension flow. As a result, the microe-
lectrodes on one side of the sensor are able to capture cells 
and serve as WEs, while the microelectrodes on the other 
side without capturing cells serve as reference microelec-
trodes. The microelectrode arrays are integrated inside a 
microfluidic channel. 
The sensor was fabricated on the Pyrex wafers based on 
the standard micro fabrication techniques. The V-shaped 
cell-capture arrays are made of SU-8 of 20 μm in height and 
fabricated in the same layer with the microchanel walls. The 
microfluidic part of the sensor chip consists of (1) micro-
channel walls with the same height as the cell capture and 
(2) a PDMS cover which was fabricated separately using 
micro moulding method [12]. Two microchannels with the 
height of 20 μm were created inside the cover. Four holes 
with a diameter of 1 mm were punched through the PDMS 
layer to produce the inlets and outlets. Two microchannels 
of 40 μm in height were formed by a natural adhesion of the 
PDMS cover onto the microchannel walls. The design and 
fabrication of a proposed sensor chip can be found in details 
in our previous works [11, 13].  
After dicing, the total size of one chip is only 11 × 
5.3mm2. The chip was glued into a double-sided printed 
circuit board (PCB) and wire bonding for the impedance 
measurement. By perforating a window through the PCB 
together with the use of a thin gold microelectrode and 
PDMS cover, the sensor chip is total “transparent”. There-
fore, it is ideal for monitoring cells inside the microchannels 
during experiments.    
 
B. Cell culture 
 
Human breast cancer cells MCF-7 were cultivated in the 
DMEM medium supplemented with 10% fetal bovine se-
rum (FBS) under the standard conditions (37°C, 5% CO2) 
inside an incubator. Cells were detached from the culture 
flasks by a treatment with trypsin-EDTA for 2 min. After a 
detachment, they were resuspended in the DMEM to inacti-
vate any remaining trypsin activities. After a centrifugation 
for 10 min, they were resuspended in the CO2 independent 
medium which is supplemented with 4 mM L-glutamine to 
the final concentration of 106 cells/ml. 
 
C. Impedance measurement 
 
The spectrum measurement was carried out by using So-
lartron impedance analyser 1260 (SI 1260). The SI 1260 
delivered an alternating voltage of 10 mV amplitude over a 
frequency range from 102 to 106 Hz. For the real-time 
measurement, the SI 1260 was set to deliver an alternating 
voltage of 10 mV at 4 kHz. 
 
D. Experiment procedure 
 
The detail of an experiment procedure can be found in 
our previous works [11]. Briefly, the wire bonded chip is 
firstly cleaned and modified. Then, the full chip is formed 
by aligning the PDMS cover on to the microchannel walls. 
Next, the cell suspended medium is injected into the chan-
nel by placing a small drop on the inlet. Single and multiple 
cells are captured on the top of microelectrodes. Finally, the 
further tasks of an experiment are able to be carried out.  
III. RESULTS 
A. Hydrodynamic trapping single and multiple cells 
Figure 2 presents a photo of a chip used in the experi-
ment (a) and a micrograph of two microelectrodes with a 
single and multiple cells on the  top (b). Only one micro-
chanel was used in each experiment. The chip can be reused 
several times by removing the PDMS cover and cleaning 
the chip surface.  After the cells were trapped on the top of 
the working microelectrodes, two drops of a cell culture 
 (b)  (a) 
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medium was placed on the inlet and the outlet. Then, the 
chip was placed into an incubator to culture cells. As shown 
in Fig. 2 (a), two working microelectrodes with cells were 
trapped and incubated. Two cells on the big-sized microe-
lectrode spread and their shapes were clearly changed while 
a shape of a single cell on the smaller one is unchanged.  
The measured spectra therefore vary correspondingly.  
 
 
 
 
 
 
 
 
 
 
 
Fig.2 (a): A photo of a chip used in the experiment.  (b): A micrograph of 
two microelectrodes with a single and multiple cells on top  
 
B. Monitoring the response of cell to anticancer drug 
 
Figure 3 describes the response of a single MCF-7 cell to 
the well-known anti-cancer drug-Cisplatin with a concentra-
tion of 100 µM after exposing for 6 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3 A Bode plot to monitor responses of a single cancer cell in the 
Cisplatin treatment: concentration of 100 µM after exposing for 6 hours. 
 
After trapping the cells on the top of the microelectrodes, 
the cells were cultured inside an incubator for 8 hours. 
Then, the medium inside the microchannels was replaced by  
physiological conditions. As shown in Fig.3, the impedance 
magnitude after exposing for 6  hours (RED line) sharply 
decreases, in comparison with the impedance magnitude, 
just after replacing the medium inside the microchannel by 
a drug medium (BLACK line). 
C. Real-time monitoring the response of cells to anticancer 
drug treatment 
The real-time monitoring of the response of the MCF-7 
cells to the anticancer drug Cisplatin treatment is illustrated 
in Fig. 4. After a cell trapping process, the cells were cul-
tured for 8 hours, so that the cells stabilise, attach, and 
spread on the microelectrode surface. Then, the medium 
inside the chip was replaced by Cisplatin to expose the cells 
to physiological conditions. The impedance measurement 
was performed for 6 hours, and the impedance magnitude 
decrease approximately 15%. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 A real-time monitoring of the response of  the MCF-7 cell in the 
Cisplatin treatment with the same concentration.  
IV. DISCUSSIONS AND CONCLUSIONS 
A successful development of a novel microfludic im-
pedance biosensor which is suitable for cell-based experi-
ments and studies is presented in this paper. The chip can 
trap a single or multiple cells on the surface of microelec-
trodes with a high efficiency for subsequent investigations. 
After capturing and culturing inside the microchannels, cell 
behaviors and their response to a surrounding environment 
or anticancer drug treatments can be evaluated. The chip 
can provide the information of a single cell in comparison 
with multiple cells. However, the influence on cell behav-
iors due to the miniature environment and the behaviors of 
cells in the long-term requires further tests. The results of 
this study have potentials for applications in the cancer cell 
research, drug screening, and quantification of cancer cells 
from various tumor stages, especially for the further re-
search and development of biosensors and lab-on-chips 
which are based on behaviors and signals from cells. 
Cancer is a global problem that accounts for almost 13% 
of deaths worldwide; and more than half of all cancer cases 
and nearly 2/3rd of global cancer deaths occur in develop-
ing countries; concretely 12.7 million new cancers were 
diagnosed worldwide in 2008, and 7 million of which were 
in developing countries [14, 15, 17]. By 2020, there will be 
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between 15 and 17 million new cases of cancer every year, 
60-70% new cases of cancer and nearly 70% of cancer 
deaths will be in economically disadvantaged countries 
[17]. Annually, there are nearly 125 thousand people which 
diagnosed with cancers in Viet Nam. However, cancer is 
potentially the most preventable disease; with current re-
sources, one-third of tumors could be preventable; and one-
third of newly diagnosed cancer patients could experience 
increased survival or early-stage detection [17].  There is an 
urgent need for a multidisciplinary approach to improve 
cancer care and reduce the rates of cancer deaths in re-
source-poor countries in which there exist a lack of access 
to cancer therapy, poor early detections of cancers and 
screening services, unfriendly health care and delivery sys-
tems, poor organization of supportive-care facilities [16, 
17]. Developments of the cost-effective solutions, including 
smart biosensors and lab-on-chips, for early detections of 
cancers are therefore important and necessary for develop-
ing countries. 
 The total healthcare spending in Vietnam was 
US$12.90 billion in 2014; it is estimated this to reach 
US$27.48 billion in 2020 at a compound annual growth rate 
of 13.4 % [18]. With the strong support and investments 
from the government via research and technology 
development (RTD) funding agencies and projects such as 
National Foundation for Science and Technology 
Development (NAFOSTED) and Fostering Innovation 
through Research, Science and Technology (FIRST), in 
collaborations with Newton Fund (UK), there are potentials 
for collaborations in Biomedical Engineering and related 
areas, especially among research institutions in Vietnam and 
UK, to develop innovative products and cost-effective 
solutions for screening, early detections, diagnosis and 
treatments of cancers for developing countries, including 
Vietnam.   
 In conclusions, we presented a microfluidic impedance 
biosensor which can be used for a real-time monitoring of a 
single or multiple tumor cells and their response to the 
anticancer drug treatment.  The results of this study open 
potential research collaborations about development of cost-
effective devices and lab-on-chips for early disease 
detection, studies of cancerous cells and their response to 
anti-cancer drugs to optimize cancer treatments, 
characterisation of mechanical properties of cells, new drug 
delivery mechanisms, and micro &nano manufacturing. 
These potential research collaborations may benefit from 
the currently available RTD resources in micro & nano 
manufacturing, nano-materials, and BME, in both Vietnam 
and UK. For the short and medium term collaborations, 
based on the successful preliminary results, the results of 
this study can be expanded to the further test and studies 
about the effects of the microenvironment on the vital of 
cells. In addition, we also aim at innovative developments 
of low-cost microfluidic platforms for developing and 
testing  new antimicrobials on the artificial cells.  
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